LAVA Medtech Acquisition Corp. Warrants
LVACW
LVACW was delisted on the 12th of May, 2023.
0 hedge funds and large institutions have $0 invested in LAVA Medtech Acquisition Corp. Warrants in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 33 closing their positions.
100% less funds holding
Funds holding: 33 → 0 (-33)
100% less capital invested
Capital invested by funds: $487K → $0 (-$487K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 33
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$130K |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$47.2K |
| 3 |
SCM
Saba Capital Management
New York
|
-$41.2K |
| 4 |
EFI
EHP Funds Inc
Toronto,
Canada
|
-$33.1K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WA
26
Whitebox Advisors
Minneapolis,
Minnesota
| – | -$1.88K | -25,000 | Closed |
|
|
SG
27
StoneX Group
New York
| – | -$1.12K | -20,300 | Closed |
|
28
Calamos Advisors
Naperville,
Illinois
| – | -$1.06K | -12,500 | Closed |
|
|
LP
29
LMR Partners
London,
United Kingdom
| – | -$130K | -12,500 | Closed |
|
|
DCM
30
Dupont Capital Management
Wilmington,
Delaware
| – | -$424 | -5,000 | Closed |
|
|
AA
31
Ancora Advisors
Cleveland,
Ohio
| – | -$143 | -1,704 | Closed |
|
32
UBS Group
Zurich,
Switzerland
| – | -$32 | -590 | Closed |
|
|
CS
33
Clear Street
New York
| – | -$38 | -500 | Closed |
|
LVACW Hedge Fund Activity: Q2 2023 in Review
0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q2 2023, worth a combined $0 — down 100% from $487K a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of LVACW and 0 opened new positions — a net loss of 33 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $130K sold.
- 0 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q2 2023, down from 33 in Q1 2023.
- Funds reported $0 of LAVA Medtech Acquisition Corp. Warrants stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q2 2023 and 33 closed out, a net change of -33 holders.
- The largest LAVA Medtech Acquisition Corp. Warrants seller in Q2 2023 was LMR Partners, an estimated $130K sold.
Based on aggregated 13F filings for Q2 2023.